A dull ache low in the back that arrives in your twenties, refuses to settle at night, and feels worse after a long meeting than a long walk is not what most people picture as back trouble. Yet that pattern is the signature of ankylosing spondylitis, a chronic inflammatory disease of the spine and of the joints anchoring it to the pelvis. Spondyloarthritis affects roughly 3.5 to 13 people per 1,000 in the United States: common in absolute numbers, easy to miss in any single appointment.
What is ankylosing spondylitis?
Ankylosing spondylitis is an immune-mediated arthritis that inflames the sacroiliac joints, where the base of the spine meets the pelvis, and often the vertebrae above. Inflammation concentrates at entheses, the points where ligaments and tendons attach to bone. Over years the body may lay down new bone, forming bridges called syndesmophytes between vertebrae, and in a minority of people spinal segments fuse.
Here is where terminology gets confusing. Rheumatology no longer treats ankylosing spondylitis as a standalone diagnosis. It sits inside a spectrum called axial spondyloarthritis, or axSpA, and is now named radiographic axial spondyloarthritis because structural damage shows on a plain X-ray. The earlier stage is non-radiographic axSpA: identical symptoms, identical biology, no X-ray damage yet, though MRI may already show inflammation.
Non-radiographic does not mean mild: pain, stiffness, and fatigue scores are broadly similar across both groups. Seeing axSpA appear on your chart is a change of vocabulary, not a new disease.
Inflammatory back pain vs mechanical back pain
This distinction is the single most useful thing to carry into a doctor’s appointment. Mechanical back pain, the ordinary kind that follows a strained muscle or bad lifting day, behaves intuitively: activity aggravates it, rest relieves it. Inflammatory back pain does the opposite, flaring during stillness and easing once you move.
| Feature | Inflammatory back pain | Mechanical back pain |
|---|---|---|
| Age at onset | Usually before 45, often 15 to 30 | Any age |
| Morning stiffness | Longer than 30 minutes | A few minutes at most |
| Response to rest | Worse; stillness stiffens it | Better; rest calms it |
| Response to exercise | Better; movement loosens it | Worse; activity aggravates it |
| Night pain | Common late in the night, often forcing you out of bed | Uncommon |
| Duration and onset | Gradual onset, three months or longer | Often sudden after an event, easing in weeks |
No single row proves anything. Clinicians look for a cluster: young onset, insidious start, long morning stiffness, night pain, and clear improvement with exercise. That combination should prompt a rheumatology referral.
Symptoms and warning signs
Symptoms usually begin in the lower back and buttocks, sometimes alternating sides. Pain can radiate into the back of the thigh but rarely below the knee, which helps separate it from sciatica. Deep fatigue is common, driven by inflammation itself. Later, some people notice reduced spinal flexibility, a stiff neck, or trouble taking a full breath.
Symptoms beyond the spine
Axial spondyloarthritis is a whole-body disease. Enthesitis, inflammation where tendons insert into bone, usually appears as a sore Achilles tendon or heel, and peripheral arthritis can swell a knee, ankle, or hip. Acute anterior uveitis, a painful red eye with light sensitivity and blurred vision, needs same-day ophthalmology attention.
Skin and gut are involved too. About one in ten people with axSpA also develops psoriasis, a scaly skin disease driven by the same interleukin-17 pathway. A smaller group develops Crohn’s disease, an inflammatory bowel condition sharing gut immune machinery with the spine disease. Mention either one, since these overlaps steer drug choice.
How AS presents differently in women
For decades ankylosing spondylitis was taught as a young man’s disease. It is not. Across the full axSpA spectrum, prevalence is close to equal between the sexes, and that old teaching is a major reason women wait longer.
Women more often report neck and peripheral joint pain, widespread enthesitis, higher symptom scores, and less visible structural damage. Structural MRI findings at the sacroiliac joints, such as fat metaplasia and erosion, also perform measurably worse as diagnostic markers in women, so an imaging-first workup is likelier to under-call disease. Diagnostic delay across axSpA is notoriously long, frequently quoted at seven to ten years, and consistently longer for women.
Causes and risk factors
Nobody develops axSpA from bad posture or heavy lifting. The disease reflects an inherited tendency for the immune system to overreact at entheses, probably triggered by ordinary exposures such as gut bacteria and mechanical stress.
HLA-B27 is the best-known genetic factor and the most misunderstood. It is a normal variant of a gene that helps immune cells display protein fragments. Most carriers are perfectly healthy, and only a small minority ever develop spondyloarthritis. Among children who inherit HLA-B27 from a parent with ankylosing spondylitis, roughly three quarters do not develop it. Carrying HLA-B27 raises risk; it does not create disease.
Other genes contribute, including ERAP1, IL1A, and IL23R, pointing toward the interleukin-23 and interleukin-17 pathways that current biologics target. A family history of spondyloarthritis, psoriasis, uveitis, or inflammatory bowel disease raises risk, and smoking tracks with faster progression.
How ankylosing spondylitis is diagnosed
There is no single confirmatory test. Diagnosis is a judgment built from the symptom pattern, a physical exam measuring spinal mobility and chest expansion, imaging, and bloodwork, organized around the Assessment of SpondyloArthritis International Society framework.
Imaging of the sacroiliac joints does the heaviest lifting. A plain X-ray can show sacroiliitis: erosion, sclerosis, joint space narrowing, and fusion. Definite X-ray change separates radiographic axSpA from the non-radiographic form, but it may take years to appear. MRI closes the gap by revealing bone marrow edema, an inflammatory signal visible long before bone remodels, though similar signal also appears after childbirth and in athletes.
The blood tests that matter
Bloodwork supports the diagnosis rather than making it. To gauge disease activity, clinicians order a C-reactive protein test that measures systemic inflammation in real time. Most rheumatology panels also include an erythrocyte sedimentation rate that rises and falls more slowly than CRP. Here is the critical caveat: a large share of people with active axSpA have entirely normal CRP and ESR, so normal markers do not rule out the disease.
To separate axSpA from look-alikes, rheumatologists check a rheumatoid factor result that is expected to come back negative in spondyloarthritis, which is why this family of diseases is called seronegative. Before any immune-modifying drug is started, the same draw yields a complete blood count that can expose the mild anemia of chronic inflammation.
HLA-B27 deserves its own sentence. It is a risk marker, not a diagnostic test. A positive result in someone with inflammatory back pain raises the probability of axSpA and can tip a borderline case toward referral, but alone it confirms nothing, and plenty of patients test negative.
Conditions AS is confused with
Because inflammatory back pain is uncommon relative to the mechanical kind, default explanations come first. Radiologists frequently report lumbar osteoarthritis, a wear-related condition that also stiffens the back after inactivity, and degenerative disc disease is a common early label. Fibromyalgia is another detour, particularly for women, since it produces widespread pain without inflammation. Within rheumatology, examiners exclude rheumatoid arthritis, a symmetric small-joint disease that largely spares the sacroiliac joints. Other mimics include diffuse idiopathic skeletal hyperostosis.
Treatment options
Exercise and physical therapy are the backbone, not the afterthought. A structured program of spinal mobility work, postural training, stretching, and conditioning improves function in a way no medication substitutes for.
Nonsteroidal anti-inflammatory drugs are the usual first-line class, and the response is often striking enough to be diagnostically informative. Ongoing use warrants attention to blood pressure, kidney function, and gastrointestinal symptoms. Conventional DMARDs such as sulfasalazine and methotrexate help peripheral joints but do little for spinal disease.
When NSAIDs are not enough, biologics come next. TNF inhibitors block tumor necrosis factor, an inflammatory messenger, and have the longest track record. IL-17 inhibitors target interleukin-17, a different signal in the same pathway, and are an alternative when TNF blockade fails; they are generally avoided alongside inflammatory bowel disease. Both classes require tuberculosis and hepatitis screening first plus ongoing vigilance for infection, and live vaccines are avoided during treatment.
JAK inhibitors are oral small molecules that interrupt intracellular signaling for several cytokines at once. They demand more monitoring: blood counts, liver enzymes, and lipids are tracked, and labeling warns about serious infection, blood clots, cardiovascular events, and cancer. Systemic corticosteroids have little role in axial disease, and surgery is reserved for advanced damage.
Daily management and posture
Small habits compound over decades. A firm mattress with a thin pillow, or briefly lying flat on your front, discourages the forward-stooped posture the disease pulls toward. Standing every 30 to 45 minutes counters the stiffening long sitting produces, and swimming allows full-range movement with little joint loading. Breathing exercises maintain chest expansion when rib joints are involved.
Complications and long-term outlook
The complication most people fear is spinal fusion, and it deserves proportion: a fully rigid spine is now the exception rather than the rule.
Two complications get less attention than they deserve. The first is bone loss driven by inflammation, so bone density testing uncovers osteoporosis that hides within a spine looking deceptively dense on X-ray. A stiffened spine behaves like a long lever, so minor falls can cause vertebral fractures. The second is cardiovascular risk, elevated in chronic inflammatory disease, which makes managing blood pressure and lipids routine.
Latest scientific advances
A 2024 systematic review and meta-analysis pooled 20 randomized controlled trials covering 1,670 people with axial spondyloarthritis to measure what structured exercise therapy delivers. Against controls, exercise improved disease activity on the BASDAI symptom questionnaire by a weighted mean difference of -0.78, the ASDAS composite activity score by -0.44, and physical function on the BASFI by -0.49, and added 27.64 meters to the six-minute walk test. It produced no significant change in CRP or ESR (Zhang et al., 2024). What this means for you: exercise measurably improves how you feel and function, even when blood markers do not move.
A 2024 systematic review and meta-analysis asked whether women wait longer for diagnosis. Across 26 studies, with 16 high-quality ones pooled, women had a mean diagnostic delay 1.48 years longer than men (95% confidence interval 0.83 to 2.14). The gap was widest in studies predating the 2009 axSpA classification criteria and outside Europe, where the pooled difference reached 3.16 years (Bandinelli et al., 2024). What this means for you: the delay women face is a documented pattern, so naming axial spondyloarthritis to your clinician is reasonable.
A 2023 network meta-analysis in Annals of the Rheumatic Diseases assessed cancer risk with JAK inhibitors across inflammatory diseases including axSpA, pooling 62 randomized trials and 16 long-term extension studies covering more than 82,000 person-years of exposure. Malignancy incidence was not significantly different from placebo or methotrexate, but was higher than with TNF inhibitors, at an incidence rate ratio of 1.50 (95% confidence interval 1.16 to 1.94). Cancers were rare in every group (Russell et al., 2023). What this means for you: this is the evidence behind the extra monitoring a JAK inhibitor requires.
Myths and facts
Myth: a positive HLA-B27 test means you have or will get ankylosing spondylitis. Fact: most carriers never develop it, and the test only adjusts probability within a clinical picture.
Myth: it is a man’s disease. Fact: across the full axSpA spectrum, prevalence is close to equal, and women are diagnosed later.
Myth: rest is the safest response to a flare. Fact: prolonged rest worsens inflammatory back pain, while graded movement helps.
Myth: everyone with the diagnosis ends up with a rigid, fused spine. Fact: progression varies widely and full fusion is now uncommon.
Glossary
| Term | What it means |
|---|---|
| Axial spondyloarthritis | Umbrella term for inflammatory disease of the spine and sacroiliac joints. |
| Radiographic axSpA | Current name for ankylosing spondylitis: axSpA with damage visible on X-ray. |
| Non-radiographic axSpA | The same disease before X-ray damage appears; MRI may show inflammation. |
| Sacroiliitis | Inflammation of the joints linking the spine to the pelvis. |
| Enthesitis | Inflammation where a tendon or ligament attaches to bone. |
| HLA-B27 | Inherited gene variant that raises spondyloarthritis risk without causing it. |
| Syndesmophyte | A bridge of new bone between vertebrae that can fuse spinal segments. |
Frequently asked questions
Is ankylosing spondylitis the same as axial spondyloarthritis?
Almost. Axial spondyloarthritis is the broader category, and ankylosing spondylitis is the subtype where damage already shows on X-ray, now called radiographic axial spondyloarthritis. The other subtype is the same disease before those changes appear. If your chart switches from one term to the other, your diagnosis has not changed; the vocabulary has been updated to match how rheumatologists now classify the condition.
Can you have ankylosing spondylitis with a negative HLA-B27 test?
Yes. HLA-B27 is strongly associated with the disease, but it is a risk marker rather than a diagnostic test. A meaningful proportion of people with confirmed axial spondyloarthritis test negative, and that proportion varies by ancestry. Diagnosis rests on the symptom pattern, the physical examination, and imaging of the sacroiliac joints, with the gene result acting as one input among several rather than the deciding one.
What does inflammatory back pain feel like?
It usually starts gradually before age 45, sits deep in the lower back or buttocks, and lasts longer than three months. The hallmark is that it improves with movement and worsens with rest, so mornings and long stretches of sitting are hardest. Stiffness on waking typically runs beyond 30 minutes, and many people wake late in the night needing to walk around before the pain settles.
Is ankylosing spondylitis hereditary?
It runs in families but is not inherited in a simple, predictable way. Multiple genes contribute, HLA-B27 most prominently, alongside environmental factors still being mapped. Having a close relative with spondyloarthritis, psoriasis, uveitis, or inflammatory bowel disease raises your risk. Even so, roughly three quarters of children who inherit HLA-B27 from an affected parent never develop the disorder, so a family history is a reason for awareness rather than for expecting disease.
Can ankylosing spondylitis be cured?
There is no cure yet, but the outlook has changed substantially. The goal of modern treatment is sustained low disease activity or remission, which many people reach through consistent exercise, appropriate medication, and regular monitoring. Since effective biologics arrived, severe fusion has become far less common than the older textbook picture suggests. Most people with axSpA work, travel, and raise families, and earlier diagnosis is associated with better long-term function.
Does exercise make ankylosing spondylitis worse?
No, and avoiding movement generally backfires. Pooled trial evidence shows structured exercise therapy improves disease activity scores, physical function, walking capacity, pain, and fatigue in axial spondyloarthritis. The useful mix combines spinal mobility and postural work, stretching, strengthening, and cardiovascular conditioning. During an acute flare, intensity may need to drop temporarily, but complete rest is rarely the right answer. A physical therapist familiar with the condition can tailor a program to you.
Sources
- National Institute of Arthritis and Musculoskeletal and Skin Diseases — Ankylosing Spondylitis — National Institutes of Health, 2025 — niams.nih.gov
- MedlinePlus Genetics — Ankylosing spondylitis — National Library of Medicine, 2025 — medlineplus.gov
- American College of Rheumatology — Axial Spondyloarthritis — American College of Rheumatology, 2025 — rheumatology.org
- Spondylitis Association of America — Ankylosing Spondylitis — Spondylitis Association of America, 2025 — spondylitis.org
- Zhang M et al. — Effects of Exercise Therapy in Axial Spondyloarthritis: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Trials — Archives of Physical Medicine and Rehabilitation, 2024 — doi.org
- Bandinelli F et al. — Sex Bias in Diagnostic Delay: Are Axial Spondyloarthritis and Ankylosing Spondylitis Still Phantom Diseases in Women? — Journal of Personalized Medicine, 2024 — doi.org
- Russell MD et al. — JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications — Annals of the Rheumatic Diseases, 2023 — doi.org
Further reading
- Our overview of arthritis maps the wider family of joint diseases that includes inflammatory and degenerative types.
- A companion article explains gout, a crystal-driven arthritis producing sudden red joint attacks unlike inflammatory back pain.
- Readers with persistent diarrhea or rectal bleeding should read our page on ulcerative colitis, an inflammatory bowel disease seen alongside axial spondyloarthritis.
- Our article on silent inflammation compares high-sensitivity CRP and standard CRP, two versions of one marker answering very different questions.
Understand your lab results with BloodSense
If you have inflammatory back pain and a folder of lab reports, inflammatory markers are what you will keep seeing. CRP and ESR track activity over time and help judge whether treatment is working, while a complete blood count adds context about anemia.
Their limits matter just as much. Both rise with any infection or injury, both are often normal in active disease, and neither can confirm or exclude a diagnosis. BloodSense turns raw numbers into plain-language explanations with reference ranges and trends, so you arrive at your appointment with better questions.
